EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Local Anaesthetic Systemic Toxicity in Dental and Oral and Maxillofacial Surgery: Safe Dosing, Combination Agents, and Emergency Management—A Narrative Review

Cemal Ucer, Simon Wright, Rabia Khan iD, Sushil Kumar

Dentistry Journal · 20.07.2026 · 14 (7) · 457

DOI: 10.3390/dj14070457 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dentistry Journal, online erschienen am 20.07.2026. Verfasst von Cemal Ucer und 3 weiteren Autor:innen. Beteiligte Einrichtung: ICE Postgraduate Dental Institute and Hospital, School of Health and Society, University of Salford, 24 Furness Quay, Salford M50 3XZ, UK. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Local anaesthetic systemic toxicity (LAST) is a rare but potentially fatal complication of dental and oral and maxillofacial surgical local anaesthesia (LA). Three amide agents are commonly used in the UK: lignocaine (lidocaine) 2% with adrenaline 1:80,000; articaine 4% with adrenaline 1:100,000 (2.2 mL cartridges); and bupivacaine 0.5%. Clinically significant discrepancies between guideline sources for maximum recommended dosages (MRDs) persist, and the additive toxicity of combined amide agents remains underappreciated. The objectives are: to provide clear, evidence-appraised MRD guidance for dental practitioners; to explain safe combination dosing using the fractional dose rule with acknowledgement of its pharmacokinetic limitations; and to outline recognition and management of LAST, including intravenous lipid emulsion (ILE) therapy, setting-stratified response, and differential diagnosis.

Methods

These include the following: narrative review of MEDLINE (via PubMed), the Cochrane Library, and Embase (inception to May 2026), supplemented by key regulatory documents (British National Formulary (BNF) 91; US Food and Drug Administration (FDA) prescribing information; UK Summaries of Product Characteristics (SmPCs)); major guideline documents (American Society of Regional Anesthesia and Pain Medicine (ASRA) 2018; Association of Anaesthetists 2021; Resuscitation Council UK 2021); systematic reviews; and peer-reviewed literature, ranked by a jurisdiction-specific UK prescribing and regulatory source hierarchy.

Results

BNF 91 and the FDA both support a 7 mg/kg (500 mg) MRD for lignocaine with adrenaline; in practice, the adrenaline ceiling limits administration to 6–7 cartridges (2.2 mL) regardless of the guideline followed. The principal reasons for caution when combining amide agents are; additive systemic toxicity, more complex dose calculation, absence of proven clinical benefit for concurrent mixing, unnecessary drug exposure, and incremental hypersensitivity risk—not metabolic pathway differences. The fractional dose rule is a pharmacologically justified safety heuristic with acknowledged pharmacokinetic limitations. ILE is a specific rescue therapy for severe or cardiovascular LAST; airway support and oxygenation remain the primary interventions. Patient-specific factors substantially lower the effective toxic threshold.

Conclusions

Safe LA administration in oral surgery requires systematic MRD calculation, application of the fractional dose rule for combined-agent appointments, attention to patient-specific risk factors, setting-appropriate emergency preparedness, and structured differential diagnosis to distinguish LAST from more common dental emergencies.

Schlagwörter

Stichwörter der Autor:innen

BNFLASTarticainebupivacainedifferential diagnosisepinephrinefractional dose ruleintravenous lipid emulsionlignocainelocal anaesthetic systemic toxicitymaximum recommended doseoral surgerysedation

Autor:innen und Institutionen

  • ICE Postgraduate Dental Institute and Hospital, School of Health and Society, University of Salford, 24 Furness Quay, Salford M50 3XZ, UK.
  • East Lancashire Hospital NHS Trusts, Casterton Ave, Burnley BB10 2PQ, UK.

ORCID-Profile: Rabia Khan

Zitieren

APA

Ucer, C., Wright, S., Khan, R., & Kumar, S. (2026). Local Anaesthetic Systemic Toxicity in Dental and Oral and Maxillofacial Surgery: Safe Dosing, Combination Agents, and Emergency Management—A Narrative Review. Dentistry Journal, 14(7), 457. https://doi.org/10.3390/dj14070457

Vancouver

Ucer C, Wright S, Khan R, Kumar S. Local Anaesthetic Systemic Toxicity in Dental and Oral and Maxillofacial Surgery: Safe Dosing, Combination Agents, and Emergency Management—A Narrative Review. Dentistry Journal. 2026;14(7):457. doi:10.3390/dj14070457

BibTeX
@article{Ucer2026,
  author = {Ucer, Cemal and Wright, Simon and Khan, Rabia and Kumar, Sushil},
  title = {Local Anaesthetic Systemic Toxicity in Dental and Oral and Maxillofacial Surgery: Safe Dosing, Combination Agents, and Emergency Management—A Narrative Review},
  journal = {Dentistry Journal},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {457},
  doi = {10.3390/dj14070457}
}
Kostenlos starten →